YOU ARE HERE : Endocrinology and Diabetes / : Faculty : Mary Zoe Baker, M.D. - Professor, Director of Clinical Services
Section Home
  A-Z list, faculty & staff
  Adjunct Faculty
  Clinical Fellows
  Clinical Staff
  Research Fellows / Post Docs
  Research Staff
  Graduate Students
  Administrative Staff
  Endocrinology Event Calendar
  Clinical Fellowship Program
  Research Programs
  Weekly Seminars
  Annual Meetings
  Program Grants
Harold Hamm Diabetes Center
Positions Available
Visit Oklahoma City
Visit Tulsa
Cost of Living Comparison
Mary Zoe Baker, MD
David Ross Boyd Professor of Medicine,
Interim Section Chief, Fellowship Director

Mailing Address:
1000 N. Lincoln Blvd., HHDC 2900
Oklahoma City, OK 73104-3252

(405) 271-5896
(405) 271-7522


Research Interests

  1. Diabetes
  2. Osteoporosis
  3. Pituitary disease
  4. Thyroid disease



1982 MD - University of Oklahoma College of Medicine, Oklahoma City, OK
1977 MS - Oklahoma State University, Stillwater, OK
1973 BA - Oklahoma State University, Stillwater, OK


Recent Publications


Smith, B. J., Leyva, M. J., Stephens, L. D., Aston, C. E., Hermann, J., Payton, M., Baker, M. Z. (2018). Relationship of American Indian blood quantum with osteoporosis risk: a cross-sectional study of American Indian women in Oklahoma. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 29(10), 2251-2260. PMID: 29943190. DOI: 10.1007/s00198-018-4594-6

Jenkins, A., Zhang, S. X., Gosmanova, A. K., Aston, C. E., Dashti, A., Baker, M. Z., Lyons, T., Ma, J.-X. (2008). Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes research and clinical practice, 82(1), e5-7. PMID: 18715664. DOI: 10.1016/j.diabres.2008.06.019


Jenkins, A. J., Gosmanova, A. K., Lyons, T. J., May, K. D., Dashti, A., Baker, M. Z., Olansky, L., Aston, C. E., Dale, G. L. (2008). Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus. Diabetes research and clinical practice, 81(2), e8-10. PMID: 18508150. DOI: 10.1016/j.diabres.2008.04.004


Hamlett S, and Baker MZ. Primary Hyperparathyroidism and Anemia. EndoTrends 16:3, 2009.

Hasan, M.K., Tierney, W.M. and Baker, MZ Severe Cholestatic Jaundice in Hyperthyroidism after Treatment with 131-Iodine. Am J Med Sci 2004; 328(6):1-3.

Howell P, Kariampuzha S, Kipgen W, Baker, MZ, Williams GR, Title T, Scofield RH. Non-surgical therapy of primary hyperparathyroidism: experience at a low volume institution. J Okla State Med Assoc, 94:561-565, 2001.

Downs, R.W., Bone, H.G., Mellwain, H., Baker, MZ, Yates, A.J., Lombardi, A., Krupa, D., Harning, R. An Open-label Extension Study of Alendronate Treatment in Elderly Women with Osteoporosis. Calcif Tissue Int 1999; 64(6):463-9.

Perry, 3rd, H. M., Bernard, M., Horowitz, M., Miller, D. K., Fleming, S., Baker, M. Z., Flaherty, J., Purushothaman, R., Hajjar, R., Kaiser, F. E., Patrick, P., Morley, J. E. (1998). The effect of aging on bone mineral metabolism and bone mass in Native American women. Journal of the American Geriatrics Society, 46(11), 1418-22. PMID: 9809765

Baker, MZ, Scofield, RH. Educational needs of internal medicine residency graduates: general internists versus subspecialists. Med Education 32:527-532, 1998.

Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, Jr, R. W., Dequeker, J., Favus, M., Alendronate Phase III Osteoporosis Treatment Study Group (1995). Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. The New England journal of medicine, 333(22), 1437-43. PMID: 7477143. DOI: 10.1056/NEJM199511303332201


Schiebinger, R. J., Baker, M. Z., Linden, J. (1987). Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion. The Journal of clinical investigation, 80(6), 1687-91. PMID: 2890660. DOI: 10.1172/JCI113258


Baker, M. Z., Badiello, R., Tamba, M., Quintiliani, M., Gorin, G. (1982). Pulse radiolytic study of hydrogen transfer from glutathione to organic radicals. International journal of radiation biology and related studies in physics, chemistry, and medicine, 41(6), 595-602. PMID: 6981616.

TOP ^  
The University of Oklahoma Health Sciences Center

Endocrinology and Diabetes
1000 N. Lincoln Blvd.; Harold Hamm Diabetes Center Building #2900
Oklahoma City, OK 73104
Phone - (405) 271-5896
FAX - (405) 271-7522

Every effort will be made to update the information contained on these pages as necessary. However, it is the responsibility ofthe user to determine that he or she is relying on the most current version of any particular information. Any questions about the material should be directed to the referenced office or department.